Winston & Strawn LLP has advised Clear Street LLC. Honigman LLP has advised Helius Medical Technologies, Inc. Reed Smith LLP has advised Pantera Capital. Cooley LLP...
Helius Medical Technologies Announces $500 Million Oversubscribed PIPE Offering
Venture Financing Partner N. Danny Shulman Joins Honigman in Washington
Honigman LLP announced that it is expanding its Washington D.C. office with the addition of N. Danny Shulman as partner. Shulman, who will be part of […]
Green Brick Partners’ $39 Million Secondary Offering of Common Stock
Greenberg Traurig advised Green Brick, and Latham advised the underwriter on the offering. Green Brick Partners, Inc. (NYSE: GRBK) announced the pricing of a secondary offering...
Rallybio’s $50 Million Common Stock Offering
Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...
POINT Biopharma’s $125 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development and global access to life-changing...
MeiraGTx’s Growth Financing Agreement with Perceptive Advisors
Latham & Watkins represented MeiraGTx in the transaction. MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage gene therapy company, announced a financing agreement with affiliates...
Unity’s Merger with ironSource
Morrison Foerster advised Unity Software Inc. on the deal, while Latham & Watkins advised ironSource. Unity Software Inc. (NYSE: U), the world’s leading platform for creating...
Stem’s $400 Million Green Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. Stem, Inc. executed its US$400 million aggregate principal amount of 0.50% Green Convertible Senior Notes due 2028 in...
Pyxis Oncology’s $168 Million Upsized Initial Public Offering
Latham & Watkins represented the underwriters in the offering. Pyxis Oncology, Inc., a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target...
Dole’s $400 Million Initial Public Offering
Skadden, Arps, Slate, Meagher & Flom, working closely to Arthur Cox, represented Dole in the offering, while Latham & Watkins represented the underwriters. Dole plc, a newly...
Sight Sciences’ $240 Million Initial Public Offering
Latham & Watkins LLP represented Sight Sciences, Inc. in the offering, while Davis Polk advised the representatives of the several underwriters. Sight Sciences, Inc. executed its initial public...
Alpha Tau’s Business Combination with Healthcare Capital Corp.
Latham & Watkins LLP represented Alpha Tau in the transaction, while Winston & Strawn represented the placement agent. Alpha Tau Medical Limited, the developer of the...